Japan Medical Dynamic Marketing: Corporate Governance Report 2024/10/01
Japan Medical Dynamic Marketing: Notice regarding the resignation of a director
Japan Medical Dynamic Marketing: Announcements of individual stocks regarding the start of sales of new commodity etf JMDM BIOCERAM AZUL ceramic head.
Japan Medical Dynamic Marketing: FY March 2025 Q1 Earnings Report (Consolidated) [Japan GAAP]
Japan Medical Dynamic Marketing: Overview of consolidated financial performance for the first quarter of the fiscal year ending in March 2025 [Japan GAAP]
Japan Medical Dynamic Marketing: Announcements of individual stocks regarding the acquisition of drug approval for the new product Ovation Tribute NEO stem for artificial joint.
Japan Medical Dynamic Marketing: Announcements of individual stocks for the MSCI ESG ETFs, "FTSE Blossom Japan Sector Relative Index", in terms of constituent selection.
Japan Medical Dynamic Marketing: Extraordinary Report
Japan Medical Dynamic Marketing: Internal Control Report - 52nd Term (2023/04/01 - 2024/03/31)
Japan Medical Dynamic Marketing: Confirmation letter
Japan Medical Dynamic Marketing: Securities report - 52nd term (April 1, 2023 - March 31, 2024)
Japan Medical Dynamic Marketing: Regarding matters related to dominant shareholders.
Japan Medical Dynamic Marketing: Report on Corporate Governance as of June 24, 2024.
Japan Medical Dynamic Marketing: 2024 General Meeting Notice and Meeting Materials
Japan Medical Dynamic Marketing: 2024 Annual General Meeting of Shareholders Convocation Notice and Shareholders' Meeting Materials
Japan Medical Dynamic Marketing: Notice regarding detailed materials on the “Long-Term VISION RT500, 1st Stage Management Plan”
Japan Medical Dynamic Marketing: Notice regarding the formulation of the “Long-Term VISION RT500, 1st Stage Management Plan”
Japan Medical Dynamic Marketing: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Japan Medical Dynamic Marketing: Overview of consolidated financial results for the fiscal year ended 2024/3 [Japanese GAAP]
Japan Medical Dynamic Marketing: Notice regarding personnel affairs of executive officers
No Data
No Data